Ikarovec Company
Ikarovec is a pre-clinical phase gene therapy company. Our programmes are aimed at treating common eye diseases, restoring sight and preventing blindness.
Founded Date:
2018-01-01
Total Funding:
3249285
Investors Number:
4
Employee Number:
1-10
Last Funding Type:
Seed
Industry:
Anti-aging Therapies
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Funding Status:
Seed
Last Funding Date:
2020-02-05